Feature | August 05, 2016| Dave Fornell

Most Popular DAIC Content in July 2016

Absorb, bioresorbable stent, FDA approval, FDA approves, FDA clears, most popular content, most popular stories, DAIC

The FDA clearance of the first bioresorbable stent, the Abbott Absorb, the first week of July has been the most popular story so far for all of 2016. It is the first fully dissolving stent approved for the U.S. market and many experts say this technology could be a paradigm shift in coronary and peripheral therapies in the coming years as the technology improves. 

 

August 5, 2016 — Here are the top 20 most popular current content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of July based on website analytics:

1. FDA Approves First Totally Bioresorbable Stent

2. Dissolving Stents May Offer New Options in the Next Decade

3. 10 Reasons Why You Need Supplemental Imaging in the Cath Lab

4. Michigan Hospital Employing Conscious Sedation for Aortic Aneurysm Repair

5. Bioresorbable Stents Are the Way of the Future

6. Study Affirms Radial Access as Default Approach for Inserting Stents

7. Update for LAA Occluder Technology News and Trends

8. University Hospitals Case Medical Center First in Midwest to Implant Abbott Absorb Stent

9. Abbott Announces Positive Clinical Results with FIRM-Guided Rotor Ablation for Atrial Fibrillation

10. FDA Clears Gore Tigris Vascular Stent for Treatment of Peripheral Artery Disease

11. FDA Clears Bioresorbable Vascular Closure Device

12. Top Trends in Cardiac Ultrasound

13. A Possible Replacement For X-ray Angiography in the Cath Lab

14. HeartFlow Introduces Next-generation FFR-CT Platform

15. Trends in Angiographic Imaging Systems

16. Advantages and Disadvantages of Novel Oral Anticoagulants

17. Key Technology Highlights in Echocardiography at ASE 2016

18. CardioKinetix Announces 500th Parachute Heart Failure Device Implantation

19. Assessing Cardiotoxicity Due to Cancer Therapy

20. Role of Imaging in Bioresorbable Stent Procedures

 

Most Popular DAIC Content in June 2016
 

Related Content

Biosense Webster Announces Initial Results From First-in-Human QDOT-FAST Study
News | Ablation Systems | May 16, 2019
Johnson & Johnson Medical Devices Companies announced that Biosense Webster, Inc.’s QDot Micro catheter...
CardioFocus Announces Results From HeartLight X3 Ablation System Pivotal Study
News | Ablation Systems | May 16, 2019
CardioFocus Inc. announced the presentation of results from its pivotal confirmatory study evaluating the HeartLight X3...
New Global Consensus Statement Addresses Catheter Ablation of Ventricular Arrhythmias
News | Ablation Systems | May 14, 2019
The Heart Rhythm Society (HRS) in partnership with three other professional societies issued an international consensus...
Netherlands Hospital to Install State-of-the-Art MRI Ablation Center
News | Ablation Systems | May 13, 2019
Imricor announced the signing of a commercial agreement with the Haga Hospital in The Hague, Netherlands to outfit a...
A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beam will ablate for a noninvasive pulmonary vein isolation procedure. Varian acquires, buys, purchases Cyberheart.

A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beams will ablate for a noninvasive pulmonary vein isolation procedure to treat an arrhythmia.

Feature | Ablation Systems | May 10, 2019 | Dave Fornell, Editor
May 10, 2019 — Radiation oncology vendor Varian announced it acquired the start-up company CyberHeart, which has deve
Ablation Reduces Risk of Dementia in Patients With AFib and Carotid Artery Disease
News | Ablation Systems | May 08, 2019
Even though many medical practitioners may opt not to perform procedures on higher-risk patients, new research finds it...
CardioFocus Announces European CE Mark Approval Of HeartLight X3 System
News | Ablation Systems | April 16, 2019
CardioFocus Inc. announced the European CE Mark approval of the HeartLight X3 Endoscopic Ablation System.
First Patient Treated With QDot Micro Ablation Catheter
News | Ablation Systems | February 04, 2019
Biosense Webster has enrolled and treated the first patient in its U.S. Investigational Device Exemption (IDE) study...
FDA Approves TactiCath Contact Force Ablation Catheter, Sensor Enabled
Technology | Ablation Systems | January 21, 2019
Abbott announced U.S. Food and Drug Administration (FDA) approval of the TactiCath Contact Force Ablation Catheter,...
First Patient Treated in STELLAR Atrial Fibrillation IDE Study
News | Ablation Systems | November 30, 2018
Johnson & Johnson Medical Devices Companies announced that Biosense Webster Inc. has enrolled and treated the first...
Overlay Init